Hata H, Matsuzaki H, Matsuno F, Yoshida M, Sonoki T, Takemoto S, Takatsuki K
2nd Department of Internal Medicine, Kumamoto University Medical School, Japan.
Acta Haematol. 1993;89(1):26-31. doi: 10.1159/000204478.
Fibronectin (FN) expression in six myeloma, two mature B-cell lines, and four T-cell lines was analyzed. All myeloma cell lines expressed FN at various levels, while mature B- and T-cell lines apparently had less FN. Moreover, an extramedullary plasmacytoma-derived myeloma cell line, KHM7, was found to secrete FN into the culture medium. Fibronectin receptors, VLA4 or VLA5, were expressed at various levels on all myeloma cell lines. An adhesion assay revealed three of six myeloma cell lines bound to FN. However, there was no correlation between binding to FN and FN receptor expression, indicating a complicated FN binding pathway. The mechanism and pathological significance of FN expression and FN binding in myeloma cells are discussed.
分析了六种骨髓瘤细胞系、两种成熟B细胞系和四种T细胞系中的纤连蛋白(FN)表达情况。所有骨髓瘤细胞系均以不同水平表达FN,而成熟B细胞系和T细胞系的FN含量明显较少。此外,发现一株源自髓外浆细胞瘤的骨髓瘤细胞系KHM7可将FN分泌到培养基中。纤连蛋白受体VLA4或VLA5在所有骨髓瘤细胞系中均以不同水平表达。一项黏附试验显示,六种骨髓瘤细胞系中有三种与FN结合。然而,与FN的结合和FN受体表达之间并无相关性,这表明FN的结合途径较为复杂。文中讨论了骨髓瘤细胞中FN表达及FN结合的机制和病理意义。